Nima Sharifi, MD

Articles by Nima Sharifi, MD

Nima Sharifi, MD, on the link between HSD3B1 and OS in prostate cancer

February 24th 2025

“We hypothesized based on prior work that specifically men with low-volume disease, if they inherit this hyperactive form of HSD3B1, they'll have shorter overall survival. It turns out that that's true,” says Nima Sharifi, MD.

Nima Sharifi, MD, on OS in CRPC associated with adrenal androgens, HSD3B1 gene

ByNima Sharifi, MD

February 13th 2025

“Of the 3 adrenal androgens, it's DHEA that seems to be most indicative of overall survival,” says Nima Sharifi, MD.

Nima Sharifi, MD

Articles by Nima Sharifi, MD

Nima Sharifi, MD, on the link between HSD3B1 and OS in prostate cancer

Nima Sharifi, MD, on OS in CRPC associated with adrenal androgens, HSD3B1 gene

Latest Updated Articles

Trending on Urology Times

FDA grants clearance to Hugo robotic-assisted surgery system for urologic procedures

Apalutamide is linked to fewer CNS-related conditions in patients with nmCRPC

Prostate MRI is linked with higher sensitivity, NPV vs micro-ultrasound in pilot study

BOND-003: Cretostimogene yields durable 24-month responses in high-grade NMIBC

Michael Cookson, MD, discusses new strategies for treatment intensification in prostate cancer